(2023)
Abrogation of greater graft failure risk of female-to-male liver transplantation with donors older than 40 years or graft macrosteatosis greater than 5%.
SCIENTIFIC REPORTS.
13,
1
(2023)
Clinical Implication of HER2 Aberration in Patients With Metastatic Cancer Using Next-Generation Sequencing: A Pan-Tumor Analysis.
JCO PRECISION ONCOLOGY.
e2200537.,
e2200537.
(2023)
Loss of F-Box and Leucine Rich Repeat Protein 5 (FBXL5) Expression Is Associated With Poor Survival in Patients With Hepatocellular Carcinoma After Curative Resection: A Two-institute Study.
CANCER GENOMICS & PROTEOMICS.
20,
3
(2023)
Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
24,
8
(2023)
Revised Nodal Staging Integrating Tumor Deposit Counts With Positive Lymph Nodes in Patients With Stage III Colon Cancer.
ANNALS OF SURGERY.
277,
4
(2023)
Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
INFLAMMATORY BOWEL DISEASES.
29,
2
(2022)
LI-RADS Version 2018 Targetoid Appearances on Gadoxetic Acid-Enhanced MRI: Interobserver Agreement and Diagnostic Performance for the Differentiation of HCC and Non-HCC Malignancy.
AMERICAN JOURNAL OF ROENTGENOLOGY.
219,
3
(2022)
Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY.
15,
(2022)
Comparative analysis of microsatellite instability by next-generation sequencing, MSI PCR and MMR immunohistochemistry in 1942 solid cancers.
PATHOLOGY RESEARCH AND PRACTICE.
233,
(2022)
Down-regulation of TRPV6 Is Associated With Adverse Prognosis in Hepatocellular Carcinoma Treated With Curative Resection.
CANCER GENOMICS & PROTEOMICS.
19,
2
(2022)
HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer.
FRONTIERS IN ONCOLOGY.
12,
(2022)
Direct comparison of the next-generation sequencing and iTERT PCR methods for the diagnosis of TERT hotspot mutations in advanced solid cancers.
BMC MEDICAL GENOMICS.
15,
1
(2022)
Sex Difference in the Tolerance of Hepatic Ischemia-reperfusion Injury and Hepatic Estrogen Receptor Expression According to Age and Macrosteatosis in Healthy Living Liver Donors.
TRANSPLANTATION.
106,
2
(2022)
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.
GENOME MEDICINE.
14,
1
(2022)
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
23,
21
(2022)
Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
102,
1
(2021)
Tumor Budding as a Prognostic Marker in Rectal Cancer Patients on Propensity Score Analysis.
ANNALS OF SURGICAL ONCOLOGY.
28,
13
(2021)
Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY.
147,
12
(2021)
Realization of improved outcomes following liver resection in hepatocellular carcinoma patients aged 75 years and older.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
101,
5
(2021)
Deep learning-based automated quantification of the hepatorenal index for evaluation of fatty liver by ultrasonography.
ULTRASONOGRAPHY.
40,
4
